Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure
- 1 March 2002
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 89 (6), 691-695
- https://doi.org/10.1016/s0002-9149(01)02341-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failureJournal of the American College of Cardiology, 2000
- Cardiac troponin I as diagnostic and prognostic marker in severe heart failureThe Journal of Heart and Lung Transplantation, 2000
- Cardiac troponins in congestive heart failureAmerican Heart Journal, 1999
- Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failureThe American Journal of Cardiology, 1999
- A novel biochemical approach to congestive heart failure: Cardiac troponin TAmerican Heart Journal, 1999
- Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAmerican Heart Journal, 1998
- Circulating Cardiac Troponin I in Severe Congestive Heart FailureCirculation, 1997
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic originThe American Journal of Cardiology, 1997
- Guidelines for the Evaluation and Management of Heart FailureCirculation, 1995